report_description,report_link,report_date,report_mdufa_period,source,page,table_number,organization,org,program,table_title,metric_type,performance_metric,fy,value,status
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,48.25,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,48.77,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,49.17,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,66.82,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,66.69,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,0,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,14,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,10,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,13,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,24,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,22,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,39,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,35,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,42,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,63,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,66,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,85,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,112,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,100,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,138,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DCD – 510(k) Time to MDUFA Decision,201,6.5,DCD,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,155,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,76.65,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,74.78,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,81.19,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,77.54,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,58.11,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,9,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,7,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,11,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,11,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,0,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,40,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,40,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,38,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,38,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,18,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,83,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,78,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,94,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,80,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,59,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,149,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,156,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,162,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,152,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DNPMD – 510(k) Time to MDUFA Decision,205,6.5,DNPMD,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,124,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2013,40.68,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2014,38.52,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2015,41.57,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2016,56,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,double,Average,2017,49.78,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,0,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,13,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,10,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,29,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,23,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,25,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,48,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,39,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,75,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,78,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,82,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,126,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DOD – 510(k) Time to MDUFA Decision,209,6.5,DOD,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,104,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2013,36.41,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2014,35.49,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2015,38.28,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2016,38.15,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,double,Average,2017,48.11,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2013,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2014,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2015,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2016,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,20th Percentile,2017,0,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2013,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2014,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2015,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2016,0,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,40th Percentile,2017,0,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2013,21,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2014,26,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2015,25,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2016,27,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,60th Percentile,2017,26,Cohort Open
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2013,62,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2014,62,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2015,67,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2016,64,Cohort Closed
"December 10, 2018 MDUFA III Performance Report (Archive)",https://public4.pagefreezer.com/content/1701303066151/FDA/20-05-2023T12:18/https://www.fda.gov/media/120475/download,2018-12-10,MDUFA 3,Table 6.5 DRH – 510(k) Time to MDUFA Decision,241,6.5,DRH,OHT8: Radiological Health,510(k),510(k) Time to MDUFA Decision,integer,80th Percentile,2017,86,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,65.45,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,68.89,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,72.39,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,94.99,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,87.4,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,18,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,20,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,17,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,28,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,28,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,63,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,67,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,64,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,92,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,102,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,152,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,154,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,152,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,175,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA IV Decision",118,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,173,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,64.8,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,66.25,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,89.59,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,103.13,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,86.67,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,19,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,20,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,29,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,39,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,36,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,65,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,68,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,81,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,102,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,94,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,146,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,140,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,159,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,177,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA IV Decision,123,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,168,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,74.93,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,95.65,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,108.07,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,106.91,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,89.39,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,5,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,5,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,29,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,53,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,55,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,63,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,42,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,94,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,118,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,128,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,119,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,93,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,165,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,174,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,179,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,173,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA IV Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,170,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,48.98,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,55.75,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,67.69,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,66.82,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,50.03,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,11,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,9,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,31,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,41,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,63,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,51,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,29,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,110,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,129,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,142,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,131,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA IV Decision,133,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,106,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,42.6,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,55.79,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,63.68,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,76.24,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,68.38,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,17,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,38,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,39,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,28,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,69,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,60,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,84,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,129,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,130,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,164,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA IV Decision,138,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,142,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,48.84,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,50.98,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,54.52,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,59.82,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,54.54,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,10,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,34,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,29,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,20,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,33,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,33,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,103,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,103,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,99,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,111,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA IV Decision,143,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,131,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,58.27,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,46.8,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,85.63,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,101.28,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,81.41,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,52,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,81,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,119,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,86,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,145,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,129,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,164,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,189,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA IV Decision,148,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,174,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2018,33.09,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2019,40.27,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2020,44.85,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2021,54.67,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,double,Average,2022,54.86,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2021,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,20th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2018,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2019,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2020,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2021,0,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,40th Percentile,2022,0,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2018,19,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2019,23,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2020,32,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2021,35,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,60th Percentile,2022,46,Cohort Open
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2018,56,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2019,81,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2020,87,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2021,105,Cohort Closed
"November 16, 2023 MDUFA IV Performance Report",https://www.fda.gov/media/173924/download?attachment,2023-11-16,MDUFA 4,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA IV Decision,152,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA IV Decision,integer,80th Percentile,2022,114,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2023,35.73,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,27,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,68,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT1 - Office of Ophthalmic, Anesthesia, Respiratory, ENT and Dental Device 510(k) Time to MDUFA V Decision",120,6.5,OHT1,"OHT1: Ophthalmic, Anesthesia, Respiratory, ENT, and Dental Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,42.79,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,36,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,85,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT2 - Office of Cardiovascular Devices 510(k) Time to MDUFA V Decision,124,6.5,OHT2,OHT2: Cardiovascular Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2023,49.44,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,4,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,48,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,103,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,"Table 6.5 OHT3 - Office of Gastrorenal, ObGyn, General Hospital, and Urology Devices 510(k) Time to MDUFA V Decision",128,6.5,OHT3,"OHT3: GastroRenal, ObGyn, General Hospital, and Urology Devices",510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,27.55,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,13,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,56,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT4 - Office of Surgical and Infection Control Devices 510(k) Time to MDUFA V Decision,132,6.5,OHT4,OHT4: Surgical and Infection Control Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,45.19,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,40,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,95,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT5 - Office of Neurological and Physical Medicine Devices 510(k) Time to MDUFA V Decision,136,6.5,OHT5,OHT5: Neurological and Physical Medicine Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,22.04,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,31,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT6 - Office of Orthopedic Devices 510(k) Time to MDUFA V Decision,140,6.5,OHT6,OHT6: Orthopedic Devices,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,31.86,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,75,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT7 - Office of In Vitro Diagnostics 510(k) Time to MDUFA V Decision,144,6.5,OHT7,OHT7: In Vitro Diagnostics,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2023,37.61,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,double,Average,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,20th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2023,0,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,40th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2023,29,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,60th Percentile,2027,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2023,71,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2024,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2025,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2026,NA,Cohort Open
"November 16, 2023 MDUFA V Performance Report",https://www.fda.gov/media/173923/download?attachment,2023-11-16,MDUFA 5,Table 6.5 OHT8 - Office of Radiological Health 510(k) Time to MDUFA V Decision,148,6.5,OHT8,OHT8: Radiological Health,510(k),510(k) Time to MDUFA V Decision,integer,80th Percentile,2027,NA,Cohort Open
